未登录

Y

Yihui Deng

Shenyang Pharmaceutical University

H指数:15

被引数:950

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Two Birds with One Stone Strategy: Sialic Acid-Modified Pitavastatin Liposomes for Combating Atherosclerosis and Tumors

Molecular Pharmaceutics

IF4.5

2026-02-060

PRE

Sialic Acid-Modified Nanoparticles in Combination Therapy with 5-Carboxy-8-hydroxyquinoline: Dual Effects of Intrinsic Blockade of Cellular Escape and Extrinsic Relief of Immunosuppression

MOLECULAR PHARMACEUTICS

IF4.5

2025-12-010

PRE

A novel sialylated nano-delivery system synergistically remodels the tumor immune-suppressive microenvironment and induces tumor detachment

一种新型唾液酸化纳米递送系统协同重塑肿瘤免疫抑制微环境并诱导肿瘤脱落

Journal of Drug Delivery Science and Technology

IF4.9

2025-11-210

PRE

Asymmetrical Branched PEG-Modified Liposomes Evade Anti-PEG Antibody Recognition to Abolish Accelerated Blood Clearance and Amplify Tumor Drug Accumulation

不对称支链PEG修饰的脂质体可逃避抗PEG抗体识别以消除加速血液清除并增强肿瘤药物蓄积

IF5.1

2025-08-140

PRE

Sialic acid-modified nanomedicines modulate neutrophils for dual therapy of cancer and sepsis: addressing neglected sepsis comorbidities during cancer treatment

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2025-02-010

PRE

Phosphatidylserine and/or Sialic Acid Modified Liposomes Increase Uptake by Tumor-associated Macrophages and Enhance the Anti-tumor Effect

AAPS PHARMSCITECH

IF4

2024-06-042

PRE

Transformable binary-prodrug nanoparticles harness heterogeneity of neutrophils to overcome multidrug resistance and promote pyroptosis in cancer

APPLIED MATERIALS TODAY

IF6.9

2024-04-011

PRE

Durable protective efficiency provide by mRNA vaccines require robust immune memory to antigens and weak immune memory to lipid nanoparticles

MATERIALS TODAY BIO

IF10.2

2024-04-011

OA

Recent advances in sialic acid-based active targeting chemoimmunotherapy promoting tumor shedding: a systematic review

IF5.1

2024-01-011

PRE

Efferocytosis: An Emerging Therapeutic Strategy for Type 2 Diabetes Mellitus and Diabetes Complications

inflammation research

IF4.1

2023-07-014

OA

Cleavable-Branched Polymer-Modified Liposomes Reduce Accelerated Blood Clearance and Enhance Photothermal Therapy

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2023-06-296

PRE

An Application of Tumor-Associated Macrophages as Immunotherapy Targets: Sialic Acid-Modified EPI-Loaded Liposomes Inhibit Breast Cancer Metastasis

AAPS PHARMSCITECH

IF4

2022-10-184

PRE

Terminating the renewal of tumor-associated macrophages: A sialic acid-based targeted delivery strategy for cancer immunotherapy

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2019-11-0134

PREAI

Targeted delivery of ibrutinib to tumor-associated macrophages by sialic acid-stearic acid conjugate modified nanocomplexes for cancer immunotherapy

ACTA BIOMATERIALIA

IF9.6

2019-07-0171

PREAI

Exhausting tumor associated macrophages with sialic acid-polyethyleneimine-cholesterol modified liposomal doxorubicin for enhancing sarcoma chemotherapy

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2019-03-0118

PREAI

Effects of stability of PEGylated micelles on the accelerated blood clearance phenomenon

聚乙二醇化胶束稳定性对加速血液清除现象的影响

DRUG DELIVERY AND TRANSLATIONAL RESEARCH

IF5.5

2018-10-3022

PREAI

Polysialic acid-polyethylene glycol conjugate-modified liposomes as a targeted drug delivery system for epirubicin to enhance anticancer efficiency

DRUG DELIVERY AND TRANSLATIONAL RESEARCH

IF5.5

2018-03-1322

PREAI

Evaluation of the antitumor effects of vitamin K2 (menaquinone-7) nanoemulsions modified with sialic acid-cholesterol conjugate

DRUG DELIVERY AND TRANSLATIONAL RESEARCH

IF5.5

2017-08-2820

PREAI

Targeted delivery of epirubicin to tumor-associated macrophages by sialic acid-cholesterol conjugate modified liposomes with improved antitumor activity

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2017-05-0187

PREAI

Evaluation of the antitumor effect of dexamethasone palmitate and doxorubicin co-loaded liposomes modified with a sialic acid-octadecylamine conjugate

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2016-10-0142

PREAI